thiolocinnamic acid

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: thiolocinnamic acid
• 英文别名: cinnamic thioacid；thiocinnamic acid；(E)-3-phenylprop-2-enethioic S-acid
• 化学式: C₉H₈OS
• 分子量: 164.228
• InChiKey: JFSTWOFGYJFLFL-VOTSOKGWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  18.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  四氢吡咯 、 thiolocinnamic acid 在 异氰酸叔丁酯 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 以83%的产率得到1-肉桂酰吡咯烷
  参考文献：
  名称：

  Thio FCMA Intermediates as Strong Acyl Donors: A General Solution to the Formation of Complex Amide Bonds

  摘要：

  Novel methodology for the formation of amide bonds under neutral conditions is described. Evidence is presented that the active acyl donors are thio FCMA intermediates, generated from the reactions of thioacids with isonitriles.

  DOI：

  10.1021/ja906005j
• 作为产物：
  描述：

  肉桂酸 在 劳森试剂 作用下， 以 二氯甲烷 为溶剂， 反应 0.17h， 以75%的产率得到thiolocinnamic acid
  参考文献：
  名称：

  用劳森试剂将羧酸转化为硫代酸的简单方法

  摘要：

  已经开发出一种使用劳森试剂将羧酸转化为硫酯的一步方案。

  DOI：

  10.1016/j.tetlet.2009.09.080

文献信息

• METHOD OF MAKING UP WITH LIGHT-SENSITIVE MAKEUP BY APPLYING A BASE LAYER AND A KIT FOR IMPLEMENTING SUCH A METHOD
  申请人：GIRON Franck

  公开号：US20100215599A1

  公开（公告）日：2010-08-26

  The present invention provides a method of making up human keratinous material with light-sensitive makeup, wherein: a) a base layer of a first composition is applied to the keratinous material, the first composition containing at least one optical agent that configured for, at least temporarily, of forming a screen at a wavelength λ; and b) a thermally stable photochromic second composition is applied on the base layer, the second composition being developable by exposure to a radiation at least of the wavelength λ.

  本发明提供了一种利用光敏化妆品修饰人类角质材料的方法，其中： a) 在角质材料上涂抹第一组分的基层，所述第一组分至少包含一种光学剂，该光学剂被配置为至少暂时地在波长λ处形成屏幕；以及 b) 在基层上涂抹热稳定的光致变色第二组分，所述第二组分可通过暴露至少波长λ的辐射来发展。
• METHOD OF MAKING UP WITH A LIGHT-SENSITIVE MAKEUP, AND A LIGHT-SENSITIVE MAKEUP COMPOSITION
  申请人：SAMAIN Henri

  公开号：US20100278761A1

  公开（公告）日：2010-11-04

  The present invention provides a method of making up human keratinous material with a light-sensitive makeup, in which: i. a layer of a thermally stable photochromic composition comprising a photochromic agent capable of being developed by UV radiation and an optical agent that screens UV radiation is applied to the keratinous material; and ii. the layer of composition is exposed in non uniform manner to UV radiation to excite the photochromic agent and create a light-sensitive makeup look, the screening power F of the composition as regards solar UV radiation (280 nm to 400 nm) being 2 or more.

  本发明提供了一种使用光敏妆容来修饰人类角质材料的方法，其中： i. 在角质材料上涂覆一层热稳定的光致变色组合物，该组合物包括能够通过紫外辐射激发的光致变色剂和用于屏蔽紫外辐射的光学剂； ii. 以不均匀的方式暴露组合物层于紫外辐射，以激发光致变色剂并创造出一种光敏妆容外观，该组合物对太阳紫外辐射（280纳米至400纳米）的屏蔽能力F为2或更高。
• [EN] CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY<br/>[FR] INHIBITEURS D'ANHYDRASE CARBONIQUE PRÉSENTANT UNE ACTIVITÉ ANTIMÉTASTATIQUE
  申请人：METASIGNAL THERAPEUTICS INC

  公开号：WO2012070024A1

  公开（公告）日：2012-05-31

  Compositions for the treatment of cancer comprising coumarin and thiocoumarin derivatives of Formulas I- XII are disclosed. Said derivatives preferentially inhibit carbonic anhydrase IX and XII (which are associated with hypoxic and metastatic tumours) over inhibiting carbonic anhydrase I and II activity. The compositions therefore are suited for treatment of hypoxic or metastatic cancers due to this selective mechanism of action.

  本发明揭示了用于治疗癌症的组合物，包括公开的具有I-XII式的香豆素和硫代香豆素衍生物。所述衍生物优先抑制与低氧和转移性肿瘤相关的碳酸酐酶IX和XII，而不是抑制碳酸酐酶I和II的活性。因此，这些组合物由于这种选择性作用机制而适用于治疗低氧或转移性癌症。
• Capping Bioprosthetic Tissue to Reduce Calcification
  申请人：Dove Jeffery

  公开号：US20090164005A1

  公开（公告）日：2009-06-25

  A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.

  一种用于植入物中使用的生物假体组织的处理方法，或者用于组装的生物假体心脏瓣膜以减少体内钙化。该方法包括将钙化减轻剂（如包埋剂或抗氧化剂）应用于组织，以特异性地抑制组织中的氧化作用。此外，该方法还可用于抑制脱水组织中的氧化作用。包埋剂抑制了组织中由氧化暴露或生成的结合位点的形成，否则这些位点在植入时会吸引钙、磷、免疫原因因子或其他钙化前体。在一种方法中，组装的生物假体心脏瓣膜中的组织叶片在脱水和灭菌之前先用醛类包埋剂进行预处理。
• Novel delta dicarbonyl compounds and methods for using same
  申请人：Beacon Laboratories, Inc.

  公开号：EP1216986A2

  公开（公告）日：2002-06-26

  Amidomethyl esters, carbonylmercaptomethyl esters, keto-containing esters, amidomethyl thioesters, amidomethyl amides, and methylene dithioesters are disclosed. The novel compounds have two carbonyl groups connected by a linking moiety having an oxygen, sulfur or nitrogen attached to a methylene group, to which is further attached a sulfur, nitrogen or CH2 group. The use of these compounds in treating illnesses and conditions, such as cancer, hemological disorders, inherited metabolic disorders and others, is also disclosed.

  披露了amidomethyl酯、羰基巯基甲酯、含酮基的酯、amidomethyl硫代酯、amidomethyl酰胺和亚甲基二硫代酯。这些新颖的化合物具有两个羰基团，通过一个连接基团连接，该连接基团具有一个氧、硫或氮连接到一个亚甲基基团，进一步连接到一个硫、氮或CH2基团。还披露了这些化合物在治疗疾病和病症，如癌症、血液疾病、遗传代谢性疾病等方面的用途。